Literature DB >> 2372655

Hexocyclium derivatives with a high selectivity for smooth muscle muscarinic receptors.

R Micheletti1, A Schiavone, E Cereda, A Donetti.   

Abstract

1. The affinity of a number of derivatives of the muscarinic antagonist, hexocyclium, containing an amidine cationic head, for guinea-pig cardiac and ileal receptors was investigated. 2. All the compounds studied displayed a greater affinity for muscular than for cardiac muscarinic receptors. 3. The 5 fold ileal selectivity of hexocyclium was increased by a number of chemical substitutions. The largest discrimination between receptors (about 200 fold) was found for the formamidine derivative. 4. The selectivity displayed by the hexocyclium derivatives stemmed from a greater decrease in affinity towards cardiac as compared to ileal receptors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2372655      PMCID: PMC1917449          DOI: 10.1111/j.1476-5381.1990.tb12067.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

1.  STEREOCHEMISTRY OF THE INTERACTION OF ENANTIOMETIC 1,3-DIOXOLANE ANALOGS OF MUSCARONE WITH CHOLINERGIC RECEPTORS.

Authors:  B BELLEAU; J PURANEN
Journal:  J Med Chem       Date:  1963-05       Impact factor: 7.446

2.  A comparison of affinity constants for muscarine-sensitive acetylcholine receptors in guinea-pig atrial pacemaker cells at 29 degrees C and in ileum at 29 degrees C and 37 degrees C.

Authors:  R B Barlow; K J Berry; P A Glenton; N M Nilolaou; K S Soh
Journal:  Br J Pharmacol       Date:  1976-12       Impact factor: 8.739

3.  The pharmacology of Flaxedil, with observations on certain analogs.

Authors:  W F RIKER; W C WESCOE
Journal:  Ann N Y Acad Sci       Date:  1951-10       Impact factor: 5.691

Review 4.  Muscarinic receptor heterogeneity in smooth muscle: binding and functional studies with AF-DX 116.

Authors:  H Ladinsky; E Giraldo; E Monferini; G B Schiavi; M A Viganò; L De Conti; R Micheletti; R Hammer
Journal:  Trends Pharmacol Sci       Date:  1988-02       Impact factor: 14.819

5.  Tissue distribution of mRNAs encoding muscarinic acetylcholine receptor subtypes.

Authors:  A Maeda; T Kubo; M Mishina; S Numa
Journal:  FEBS Lett       Date:  1988-11-07       Impact factor: 4.124

6.  Cardioselective profile of AF-DX 116, a muscarine M2 receptor antagonist.

Authors:  A Giachetti; R Micheletti; E Montagna
Journal:  Life Sci       Date:  1986-05-05       Impact factor: 5.037

7.  Muscarinic receptor heterogeneity in guinea pig intestinal smooth muscle: binding studies with AF-DX 116.

Authors:  E Giraldo; E Monferini; H Ladinsky; R Hammer
Journal:  Eur J Pharmacol       Date:  1987-09-23       Impact factor: 4.432

8.  Muscarinic M2 receptors in bovine tracheal smooth muscle: discrepancies between binding and function.

Authors:  A F Roffel; C R Elzinga; R G Van Amsterdam; R A De Zeeuw; J Zaagsma
Journal:  Eur J Pharmacol       Date:  1988-08-09       Impact factor: 4.432

9.  Binding profile of a novel cardioselective muscarine receptor antagonist, AF-DX 116, to membranes of peripheral tissues and brain in the rat.

Authors:  R Hammer; E Giraldo; G B Schiavi; E Monferini; H Ladinsky
Journal:  Life Sci       Date:  1986-05-05       Impact factor: 5.037

10.  Characterization of muscarinic receptors in guinea pig ileum longitudinal smooth muscle.

Authors:  E Giraldo; M A Viganò; R Hammer; H Ladinsky
Journal:  Mol Pharmacol       Date:  1988-06       Impact factor: 4.436

  10 in total
  2 in total

1.  4-DAMP analogues reveal heterogeneity of M1 muscarinic receptors.

Authors:  R Micheletti; L Giudici; M Turconi; A Donetti
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

2.  Binding and functional properties of hexocyclium and sila-hexocyclium derivatives to muscarinic receptor subtypes.

Authors:  M Waelbroeck; J Camus; M Tastenoy; R Feifel; E Mutschler; R Tacke; C Strohmann; K Rafeiner; J F Rodrigues de Miranda; G Lambrecht
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.